Allergan Press Releases

DUBLIN, Sept. 20, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced a partnership with actor Scott Eastwood in honor of World Alzheimer's Day, September 21, a day used as a focal point by organizations globally to raise awareness for Alzheimer's disease and the sacrifices caregivers make every day for their loved ones.

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced clinical study results of higher doses of BOTOX^® Cosmetic compared to BOTOX^® Cosmetic 20 unit dose at week 24 in patients with moderate to severe glabellar lines. Allergan conducted this trial to evaluate the duration of effect and safety of BOTOX^® Cosmetic 40, 60, and 80 unit doses versus BOTOX^® Cosmetic 20 unit dose in patients with moderate to severe glabellar lines. The primary efficacy endpoint was met and was statistically significant for BOTOX^® Cosmetic 40 and 80 units versus 20 unit in 226 subjects at 24 weeks (analysis, ?1 point improvement in Facial Wrinkle Scale (FWS) from baseline assessed by Investigator at Maximum Frown). 

DUBLIN, Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today hosted its first ever Medical Aesthetics Analyst Day where the Company outlined its industry-leading portfolio and pipeline and key initiatives to drive future growth, as well as presented an overview of the global medical aesthetics market.

DUBLIN and NEWPORT BEACH, Calif., Sept. 14, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced it has agreed to acquire Bonti, Inc., a privately held clinical-stage biotechnology company focused on the development and commercialization of novel, fast-acting neurotoxin programs for aesthetic and therapeutic applications.

DUBLIN, Sept. 12, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the launch of Spotlyte™ – an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines. Through well-researched content, product reviews and insider profiles, together with the latest beauty news and trends, the site functions as a holistic and informative lens into these worlds. Beyond the editorial, Spotlyte will provide access to a team of trained specialists ready to offer real-time support and chat directly with anyone considering medical aesthetic treatments, as well as help connect readers to local licensed providers.

DUBLIN, Sept. 10, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, today announced that it will host a Medical Aesthetics Day event and webcast on Friday, September 14, 2018. The investor event will include presentations on Allergan's industry-leading Medical Aesthetics business and pipeline.

DUBLIN, Sept. 6, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced the launch of the new SkinMedica^® LUMIVIVE™ System,  an innovative skincare product designed with two distinct formulas - one to shield skin from blue light and environmental aggressors during the day and another to recharge the skin's essential repair process at night. During the day, LUMIVIVE™ offers  full atmospheric protection and fights the signs of aging for optimal skin health and vitality. At night, LUMIVIVE™ supports the skin's ability to repair itself overnight, restoring the appearance of a glowing, youthful complexion. Unlike any other product on the market, the innovative LUMIVIVE™ System formulas work around the clock to support optimal skin vitality and radiance, and doesn't fade throughout the day or wash off, providing 24-hour protection and revitalization.

DUBLIN, Sept. 4, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Morgan Stanley Global Healthcare Conference in New York, NY. The presentation will begin at 10:00 a.m. Eastern Time on Thursday, September 13, 2018.

DUBLIN, Aug. 30, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced that Chairman and CEO Brent Saunders will participate in a fireside chat at the 2018 Wells Fargo Healthcare Conference in Boston, Massachusetts. The presentation will begin at 9:05 a.m. Eastern Time on Wednesday, September 5, 2018.

DUBLIN, Aug. 29, 2018 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that Paul Bisaro will be retiring from its Board of Directors, as part of the company's ongoing board refreshment process. Mr. Bisaro has served on the board of directors since 2007 when he joined Watson Laboratories as its CEO.